Bailard, Inc. Dbv Technologies S.A. Transaction History

Bailard, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 16, 2020	SELL	$2.33 - $12.98 $291,250 - $1.62 Million	-125,000 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$6.75 - $11.15 $843,750 - $1.39 Million	125,000 New	125,000 $1.34 Million
Q3 2019 Oct 18, 2019	SELL	$8.57 - $10.72 $1.97 Million - $2.47 Million	-230,000 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$7.58 - $10.0 $886,860 - $1.17 Million	-117,000 Reduced 33.72%	230,000 $1.89 Million
Q1 2019 Apr 24, 2019	BUY	$5.81 - $9.37 $2.02 Million - $3.25 Million	347,000 New	347,000 $2.68 Million
Q4 2018 Feb 05, 2019	SELL	$5.75 - $21.85 $425,500 - $1.62 Million	-74,000 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$16.81 - $24.58 $453,869 - $663,660	27,000 Added 57.45%	74,000 $1.66 Million
Q1 2018 May 07, 2018	BUY	$20.86 - $26.6 $980,420 - $1.25 Million	47,000 New	47,000 $1.08 Million

253K

Ticker DBVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,776,992
Market Cap $124M
Description
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical trial for the treatment of peanut allergies in 4 to 11 years of age children, adolescents...

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

Stay updated on Bailard, Inc. with notifications on news.